Suzanne Shusterman
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
ORCID: 0000-0002-5988-1792Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Hersh Gupta, Abigail Ward, Yvonne Li, Duong Doan, Alyaa Al‐Ibraheemi +28 more
Papers
Driven by 7 papers — median percentile 54. Top paper: “Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors”.
Brigitte C. Widemann, Pamela S. Hinds, Rochelle Bagatell, Suzanne Shusterman, Emily Stern +12 more
Hersh Gupta, Abigail Ward, Yvonne Li, Duong Doan, Alyaa Al‐Ibraheemi +28 more
Jesse Smith, Yiwang Zhou, Rochelle Bagatell, Justin N. Baker, Susan L. Cohn +10 more
Meaghan Granger, Susan Groshen, Denice Tsao‐Wei, Anasheh Shamirian, Scarlett Czarnecki +15 more
Mark A. Applebaum, Theodore Karrison, Akosua Y. Oppong, Cindy Yuan, Katherine R. Berg +14 more
S. Shaaban, Jie Jane Chen, Rochelle Bagatell, Benjamin Lerman, Paul J. Catalano +20 more
Karen J. Marcus, Steven G. DuBois, Paul J. Catalano, Suzanne Shusterman, Myrsini Ioakeim‐Ioannidou +6 more